RSPI

PNK:RSPI

RespireRx Pharmaceuticals Inc.

  • Stock

USD

Last Close

0.00

24/09 20:00

Market Cap

584.67K

Beta: 0.34

Volume Today

1.40M

Avg: 379.61K

PE Ratio

−0.23

PFCF: −2.51

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
average inventory
12.11K
-
12.11K
0%
average payables
1.46M
-
1.46M
0%
average receivables
24K
-
24K
0%
book value per share
-94.50
-
-37.10
60.74%
-24.20
34.79%
-29.47
21.80%
-18.01
38.89%
-17.11
5.01%
-19.05
11.34%
-0.03
99.84%
-0.11
263.23%
-0.11
5.79%
capex per share
-0.31
-
-0.02
93.20%
capex to depreciation
-11.09
-
-0.35
96.84%
capex to operating cash flow
0.02
-
0.00
90.72%
capex to revenue
-0.30
-
-0.03
90.37%
cash per share
0.32
-
2.74
747.47%
0.45
83.61%
0.49
9.79%
0.35
28.90%
0.10
71.71%
0.04
57.01%
0.00
99.99%
0.00
395.93%
0.00
95.00%
days of inventory on hand
days payables outstanding
days sales outstanding
284.11
-
debt to assets
11.50
-
1.44
87.48%
5.92
310.99%
4.72
20.31%
5.90
25.06%
10.06
70.63%
36.05
258.24%
19.79
45.12%
9.96
49.69%
118.90
1,094.37%
debt to equity
-0.14
-
-0.26
84.03%
-0.30
15.11%
-0.20
33.43%
-0.26
31.38%
-0.22
17.35%
-0.22
0.69%
-0.21
4.88%
-0.21
0.56%
-0.23
9.80%
dividend yield
earnings yield
-0.32
-
-0.31
2.54%
-0.83
167.68%
-1.77
112.10%
-1.56
11.97%
-1.19
23.56%
-6.45
441.80%
-0.65
89.97%
-3.74
479.13%
-7.90
110.98%
enterprise value
4.34M
-
9.11M
109.76%
7.96M
12.58%
6.23M
21.74%
3.82M
38.67%
3.39M
11.15%
2.01M
40.84%
9.18M
357.12%
3.11M
66.12%
2.96M
4.68%
enterprise value over ebitda
-3.81
-
-2.09
45.06%
-1.52
27.29%
-0.74
51.62%
-0.90
22.37%
-1.56
73.18%
-1.16
25.85%
-2.77
139.44%
-1.22
56.11%
-1.80
47.79%
ev to operating cash flow
-23.80
-
-10.28
56.80%
-6.14
40.25%
-4.69
23.66%
-5.48
16.90%
-7.94
44.91%
-4.12
48.16%
-17.90
334.62%
-3.25
81.82%
-20.60
533.34%
ev to sales
147.67
-
91.59
37.98%
free cash flow per share
-4.12
-
-15.25
270.43%
-10.98
28.00%
-7.13
35.07%
-2.88
59.56%
-1.28
55.75%
-1.25
2.15%
-0.00
99.84%
-0.01
445.48%
-0.00
88.06%
free cash flow yield
-0.05
-
-0.10
114.37%
-0.18
74.58%
-0.25
40.18%
-0.25
0.68%
-0.20
22.40%
-1.25
536.04%
-0.07
94.52%
-0.93
1,252.05%
-0.56
39.24%
graham net net
-95.35
-
-40.30
57.74%
-24.98
38.01%
-30.23
21.02%
-18.46
38.92%
-17.38
5.88%
-19.12
10.02%
-0.03
99.84%
-0.12
266.92%
-0.11
7.53%
graham number
240.08
-
195.22
18.69%
165.65
15.15%
181.20
9.39%
84.80
53.20%
54.56
35.66%
52.56
3.67%
0.11
99.78%
0.33
191.32%
0.21
37.49%
income quality
0.15
-
0.33
115.47%
0.22
33.56%
0.14
33.78%
0.16
12.82%
0.16
1.52%
0.23
39.85%
0.12
48.28%
0.30
154.92%
0.07
77.49%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
interest coverage
-20.20
-
-37.11
83.75%
-5.80
84.36%
-14.45
148.93%
-41.55
187.57%
-15.98
61.55%
-4.29
73.14%
-6.08
41.57%
-3.53
41.88%
-2.62
25.92%
interest debt per share
14.73
-
11.70
20.55%
14.93
27.61%
9.06
39.29%
5.17
42.91%
4.14
20.05%
5.22
26.12%
0.01
99.83%
0.03
267.94%
0.03
6.21%
inventory turnover
invested capital
-0.14
-
-0.26
84.03%
-0.30
15.11%
-0.20
33.43%
-0.26
31.38%
-0.22
17.35%
-0.22
0.69%
-0.21
4.88%
-0.21
0.56%
-0.23
9.80%
market cap
3.76M
-
8.69M
131.22%
7.15M
17.74%
5.22M
27.01%
2.76M
47.18%
2.18M
20.99%
390.85K
82.06%
7.50M
1,818.43%
1.03M
86.21%
256.04K
75.23%
net current asset value
-4.19M
-
-2.28M
45.56%
-2.92M
28.17%
-5.53M
89.29%
-4.37M
20.94%
-5.74M
31.16%
-7.44M
29.78%
-8.06M
8.31%
-10.01M
24.11%
-11.88M
18.71%
net debt to ebitda
-0.51
-
-0.10
81.38%
-0.15
62.83%
-0.12
22.86%
-0.25
110.01%
-0.56
122.88%
-0.93
66.65%
-0.51
45.51%
-0.81
59.86%
-1.64
102.24%
net income per share
-27.11
-
-45.65
68.41%
-50.40
10.40%
-49.51
1.76%
-17.75
64.16%
-7.73
56.42%
-6.45
16.65%
-0.02
99.71%
-0.04
133.65%
-0.02
58.53%
operating cash flow per share
-4.12
-
-14.94
262.89%
-10.96
26.65%
-7.13
34.94%
-2.88
59.56%
-1.28
55.75%
-1.25
2.15%
-0.00
99.84%
-0.01
445.48%
-0.00
88.06%
payables turnover
receivables turnover
1.28
-
research and ddevelopement to revenue
9.60
-
19.64
104.61%
return on tangible assets
-23.17
-
-6.76
70.81%
-40.88
504.40%
-39.47
3.45%
-22.03
44.18%
-20.87
5.28%
-55.59
166.36%
-56.96
2.48%
-18.54
67.46%
-88.77
378.85%
revenue per share
1.04
-
0.73
29.34%
roe
0.29
-
1.23
328.96%
2.08
69.28%
1.68
19.34%
0.99
41.36%
0.45
54.12%
0.34
25.13%
0.60
77.61%
0.39
35.67%
0.17
55.98%
roic
0.32
-
1.05
229.83%
2.94
179.58%
2.09
28.95%
1.34
35.91%
0.54
59.82%
0.36
33.79%
0.59
64.47%
0.40
32.18%
0.17
58.29%
sales general and administrative to revenue
62.00
-
41.65
32.83%
shareholders equity per share
-94.50
-
-37.10
60.74%
-24.20
34.79%
-29.47
21.80%
-18.01
38.89%
-17.11
5.01%
-19.05
11.34%
-0.03
99.84%
-0.11
263.23%
-0.11
5.79%
stock based compensation to revenue
52.39
-
31.14
40.56%
tangible asset value
-4.19M
-
-2.20M
47.46%
-2.86M
30.08%
-5.49M
91.93%
-4.36M
20.72%
-5.73M
31.64%
-7.44M
29.85%
-8.06M
8.31%
-10.01M
24.11%
-11.88M
18.71%
tangible book value per share
-94.50
-
-37.10
60.74%
-24.20
34.79%
-29.47
21.80%
-18.01
38.89%
-17.11
5.01%
-19.05
11.34%
-0.03
99.84%
-0.11
263.23%
-0.11
5.79%
working capital
-4.19M
-
-2.28M
45.56%
-2.92M
28.17%
-5.53M
89.29%
-4.37M
20.94%
-5.74M
31.16%
-7.44M
29.78%
-8.06M
8.31%
-9.71M
20.47%
-11.71M
20.51%

All numbers in USD (except ratios and percentages)